Table 3 Response to treatment at follow-ups throughout the study, n (%)
Single dose | Repeated dose | P | |
|---|---|---|---|
Subjects, n | 44 | 37 | |
1 mo | 35 (79.5) | 31 (83.8) | 0.202 |
2 mo | 40 (90.9) | 31 (83.8) | 0.168 |
3 mo | 40 (90.9) | 31 (83.8) | 0.168 |
4 mo | 35 (79.5) | 24 (64.9) | 0.068 |
5 mo | 31 (70.5) | 23 (62.2) | 0.137 |
6 mo | 27 (61.4) | 19 (51.4) | 0.119 |